Drug Fail | GenomeWeb

Drug Fail

The failure rate for the approval of new drugs is bad, everyone knows that. But it may be worse than most everyone thought, writes Derek Lowe, who summarizes the latest data on drug success rates in the blog Corante.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.